168 related articles for article (PubMed ID: 31316180)
1. Rifampicin induces clathrin-dependent endocytosis and ubiquitin-proteasome degradation of MRP2 via oxidative stress-activated PKC-ERK/JNK/p38 and PI3K signaling pathways in HepG2 cells.
Xu BY; Tang XD; Chen J; Wu HB; Chen WS; Chen L
Acta Pharmacol Sin; 2020 Jan; 41(1):56-64. PubMed ID: 31316180
[TBL] [Abstract][Full Text] [Related]
2. 4-Phenylbutyrate protects against rifampin-induced liver injury via regulating MRP2 ubiquitination through inhibiting endoplasmic reticulum stress.
Chen J; Wu H; Tang X; Chen L
Bioengineered; 2022 Feb; 13(2):2866-2877. PubMed ID: 35045794
[TBL] [Abstract][Full Text] [Related]
3. Rifampicin-induced injury in HepG2 cells is alleviated by TUDCA via increasing bile acid transporters expression and enhancing the Nrf2-mediated adaptive response.
Zhang W; Chen L; Feng H; Wang W; Cai Y; Qi F; Tao X; Liu J; Shen Y; Ren X; Chen X; Xu J; Shen Y
Free Radic Biol Med; 2017 Nov; 112():24-35. PubMed ID: 28688954
[TBL] [Abstract][Full Text] [Related]
4. Canalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis.
Chai J; Cai SY; Liu X; Lian W; Chen S; Zhang L; Feng X; Cheng Y; He X; He Y; Chen L; Wang R; Wang H; Boyer JL; Chen W
J Hepatol; 2015 Dec; 63(6):1440-8. PubMed ID: 26212029
[TBL] [Abstract][Full Text] [Related]
5. High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling.
Singh AB; Guleria RS; Nizamutdinova IT; Baker KM; Pan J
J Cell Physiol; 2012 Jun; 227(6):2632-44. PubMed ID: 21882190
[TBL] [Abstract][Full Text] [Related]
6. Sustained intrahepatic glutathione depletion causes proteasomal degradation of multidrug resistance-associated protein 2 in rat liver.
Sekine S; Mitsuki K; Ito K; Kugioka S; Horie T
Biochim Biophys Acta; 2012 Jun; 1822(6):980-7. PubMed ID: 22330094
[TBL] [Abstract][Full Text] [Related]
7. Activation of p38 mitogen-activated protein kinase (p38 MAPK), extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) during hypoxia in cerebral cortical nuclei of guinea pig fetus at term: role of nitric oxide.
Maulik D; Ashraf QM; Mishra OP; Delivoria-Papadopoulos M
Neurosci Lett; 2008 Jul; 439(1):94-9. PubMed ID: 18511197
[TBL] [Abstract][Full Text] [Related]
8. Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/CREB, PI3K/Akt/IkappaB/NF-kappaB and p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1 pathway.
Lee HY; Crawley S; Hokari R; Kwon S; Kim YS
Int J Oncol; 2010 Apr; 36(4):941-53. PubMed ID: 20198339
[TBL] [Abstract][Full Text] [Related]
9. Role of JNK and p38 MAPK in Taiwanin A-induced cell death.
Ho PJ; Chou CK; Yeh SF
Life Sci; 2012 Dec; 91(25-26):1358-65. PubMed ID: 23123629
[TBL] [Abstract][Full Text] [Related]
10. Activation of extracellular signal-regulated kinase during silibinin-protected, isoproterenol-induced apoptosis in rat cardiac myocytes is tyrosine kinase pathway-mediated and protein kinase C-dependent.
Zhou B; Wu LJ; Tashiro S; Onodera S; Uchiumi F; Ikejima T
Acta Pharmacol Sin; 2007 Jun; 28(6):803-10. PubMed ID: 17506939
[TBL] [Abstract][Full Text] [Related]
11. ERK1/2 and p38 MAPKs are complementarily involved in estradiol 17ß-D-glucuronide-induced cholestasis: crosstalk with cPKC and PI3K.
Boaglio AC; Zucchetti AE; Toledo FD; Barosso IR; Sánchez Pozzi EJ; Crocenzi FA; Roma MG
PLoS One; 2012; 7(11):e49255. PubMed ID: 23166621
[TBL] [Abstract][Full Text] [Related]
12. ERK1/2 activation modulates pyocyanin-induced toxicity in A549 respiratory epithelial cells.
Forbes A; Davey AK; Perkins AV; Grant GD; McFarland AJ; McDermott CM; Anoopkumar-Dukie S
Chem Biol Interact; 2014 Feb; 208():58-63. PubMed ID: 24316274
[TBL] [Abstract][Full Text] [Related]
13. Cadmium induces apoptosis in pancreatic β-cells through a mitochondria-dependent pathway: the role of oxidative stress-mediated c-Jun N-terminal kinase activation.
Chang KC; Hsu CC; Liu SH; Su CC; Yen CC; Lee MJ; Chen KL; Ho TJ; Hung DZ; Wu CC; Lu TH; Su YC; Chen YW; Huang CF
PLoS One; 2013; 8(2):e54374. PubMed ID: 23405080
[TBL] [Abstract][Full Text] [Related]
14. Induction of TRIM22 by IFN-γ Involves JAK and PC-PLC/PKC, but Not MAPKs and pI3K/Akt/mTOR Pathways.
Gao B; Xu W; Wang Y; Zhong L; Xiong S
J Interferon Cytokine Res; 2013 Oct; 33(10):578-87. PubMed ID: 23659673
[TBL] [Abstract][Full Text] [Related]
15. Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells.
Kim MJ; Choi SY; Park IC; Hwang SG; Kim C; Choi YH; Kim H; Lee KH; Lee SJ
Mol Cancer Res; 2008 Nov; 6(11):1718-31. PubMed ID: 19010820
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 stimulates preadipocyte growth via the PKC, STAT3, AMPK, c-JUN, ERK, sphingosine kinase, and sphingomyelinase pathways.
Siao AC; Lin YY; Shih LJ; Tsuei YW; Chuu CP; Kuo YC; Kao YH
Am J Physiol Cell Physiol; 2020 Nov; 319(5):C839-C857. PubMed ID: 32755450
[TBL] [Abstract][Full Text] [Related]
17. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity.
Chuang SM; Liou GY; Yang JL
Carcinogenesis; 2000 Aug; 21(8):1491-500. PubMed ID: 10910949
[TBL] [Abstract][Full Text] [Related]
18. PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2.
Hu CT; Cheng CC; Pan SM; Wu JR; Wu WS
Cell Signal; 2013 Jun; 25(6):1457-67. PubMed ID: 23524339
[TBL] [Abstract][Full Text] [Related]
19. Involvement of oxidative stress-activated JNK signaling in the methamphetamine-induced cell death of human SH-SY5Y cells.
Wang SF; Yen JC; Yin PH; Chi CW; Lee HC
Toxicology; 2008 Apr; 246(2-3):234-41. PubMed ID: 18325654
[TBL] [Abstract][Full Text] [Related]
20. SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes.
Henklova P; Vrzal R; Papouskova B; Bednar P; Jancova P; Anzenbacherova E; Ulrichova J; Maurel P; Pavek P; Dvorak Z
Eur J Pharmacol; 2008 Sep; 593(1-3):16-23. PubMed ID: 18655782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
